1994
DOI: 10.1136/oem.51.5.323
|View full text |Cite
|
Sign up to set email alerts
|

Mortality, morbidity, and haematological results from a cohort of long-term workers involved in 1,3-butadiene monomer production.

Abstract: A retrospective mortality analysis and prospective morbidity and haematological analyses were performed for Shell Deer Park Manufacturing Complex (DPMC) male employees who worked in jobs with potential exposure to 1,3-butadiene from 1948 to 1989. 614 employees qualified for the mortality study , 438 of those were still employed during the period of the morbidity study , and 429 of those had haematological data available for analysis. Industrial hygiene data from 1979 to 1992 showed that most butadiene exposure… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0

Year Published

1998
1998
2023
2023

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(6 citation statements)
references
References 19 publications
(3 reference statements)
0
6
0
Order By: Relevance
“…This study showed a clear increased risk of leukaemia, based on 58 deaths, with a dose-response (RRs 1.0 (reference group), 1.5 (95% CI 0.7-3.2) and 1.7 (95% CI 0.8-3.9) in the three categories of increasing butadiene exposure; P-value of test for linear trend 0.03), which was not explained by exposure to styrene or other agents. These results receive a limited support by the only other large cohort study conducted Environmental and occupational cancer P Boffetta among butadiene production workers (Divine and Hartman, 1996), while no clear excess was present in the remaining, smaller studies (Bond et al, 1992;Cowles et al, 1994;Ward et al, 1996). Overall, the presence of a causal association between butadiene exposure and occurrence of cancer (leukaemia in particular) in humans is plausible: this conclusion is supported by a single large and very carefully conducted study and is compatible with the results of an additional valid, although less informative, study.…”
Section: Suspected Carcinogensmentioning
confidence: 73%
“…This study showed a clear increased risk of leukaemia, based on 58 deaths, with a dose-response (RRs 1.0 (reference group), 1.5 (95% CI 0.7-3.2) and 1.7 (95% CI 0.8-3.9) in the three categories of increasing butadiene exposure; P-value of test for linear trend 0.03), which was not explained by exposure to styrene or other agents. These results receive a limited support by the only other large cohort study conducted Environmental and occupational cancer P Boffetta among butadiene production workers (Divine and Hartman, 1996), while no clear excess was present in the remaining, smaller studies (Bond et al, 1992;Cowles et al, 1994;Ward et al, 1996). Overall, the presence of a causal association between butadiene exposure and occurrence of cancer (leukaemia in particular) in humans is plausible: this conclusion is supported by a single large and very carefully conducted study and is compatible with the results of an additional valid, although less informative, study.…”
Section: Suspected Carcinogensmentioning
confidence: 73%
“…Utility workers are employed in power generation and in water supply and treatment operations and would have had low exposure to monomers. Meinhardt et al 5 22 did not provide data on laryngeal cancer. Divine et al 6 found slightly more than expected deaths from laryngeal cancer in some subgroups of butadiene production plant workers, but the results were based on small numbers.…”
Section: Discussionmentioning
confidence: 99%
“…Men entered the study if they had been employed for at least 5 years in jobs with potential exposure to butadiene. There were no deaths due to cancer of the lymphatic and hematopoietic tissue (540). In the most recent follow-up, three deaths due to cancer of the lymphatic and hematopoietic tissues were observed (SMR ¼ 1.1; 95% CI, 0.3-1.5), and no deaths from leukemia were observed, whereas one death was expected (552).…”
Section: Clinical Casesmentioning
confidence: 88%